Moran Ben David Shapira

As Chief Business Development Officer at VLX, Moran brings with her a rich interdisciplinary background and skills at the cross-section of pharma drug development, biology and business and IP law from blockbuster-drugs IP litigation to evaluation of new technologies, biological and business opportunities as well as management of collaborations worldwide.

Moran’s experience includes various business strategy positions such as Head of Business Development at Pharma Two B in Israel leadership positions in global strategic partnership and alliance management at GlaxoSmithKline, Novartis, and Takeda in Boston. Moran is seasoned in establishing partnerships for early stage innovative projects and clinical development. Before joining the pharmaceutical industry, Moran was a practicing lawyer, specializing in patent litigation for pharmaceutical companies. Moran holds a BS in Biology from Tel Aviv University, a dual degree from IDC in Finance and Law, and an MBA from Boston University.

Connect with Moran Ben on LinkedIn.